top of page
Search
  • Writer's pictureFutureMeds

FutureMeds Proudly Appoints Christophe Berthoux as Chairman

Updated: Jan 24, 2023


We are extremely proud to welcome Christophe Berthoux as Chairman of FutureMeds and are excited to bring his vast amount of global industry experience to help shape our drug development solutions.



About FutureMeds


FutureMeds is a fast-growing independent Dedicated Research Site Network supporting pharmaceutical companies, Sponsors and CROs and contributing to research to find effective treatments and medications for all patients who need them.


FutureMeds’ Dedicated Research Site teams strive to accelerate study timelines, streamline processes, lower costs and improve data quality to help accelerate patient access to new treatments.


Through acquisitions and a strategic focus on patient experience, FutureMeds has developed qualified patient pools across Europe that enables faster patient enrollment and strong retention and help generate more accurate results.


Follow us on LinkedIn


Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.

Σχόλια


Ο σχολιασμός έχει απενεργοποιηθεί.
bottom of page